Viking Therapeutics, Inc. 4
4 · Viking Therapeutics, Inc. · Filed Jan 5, 2017
Insider Transaction Report
Form 4
MORNEAU MICHAEL
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-01-05+95,000→ 95,000 totalExercise: $1.23From: 2018-01-05Exp: 2027-01-05→ Common Stock (95,000 underlying) - Award
Stock Option (Right to Buy)
2017-01-05+17,605→ 17,605 totalExercise: $1.23From: 2017-01-05Exp: 2027-01-05→ Common Stock (17,605 underlying)
Footnotes (2)
- [F1]25% of the shares subject to the option will vest on each anniversary of the grant date.
- [F2]The Reporting Person's employment agreement with the Issuer entitles him to an annual cash bonus. The Reporting Person voluntarily elected to be paid 20% of his 2016 annual cash bonus in the form of an option to purchase shares of common stock of the Issuer.